What AI is telling the market now that ASCO is over

Generative Engine Optimization (GEO) looks at how AI assistants like ChatGPT and OpenEvidence answer real questions about a brand, trial, or therapy area, since these engines are increasingly the first place audiences turn for health information.

Ahead of ASCO, we ran a consistent set of prompts across four leading AI engines to capture a baseline of what AI was already saying about the top oncology brands and trials heading into the meeting. Once the data landed at the conference, we re-ran the same prompts to see what moved and what didn’t; which stories AI picked up, which brands gained or lost visibility, and which narratives held steady. The result is a before-and-after read that shows how AI is now shaping the market’s first draft of the story.

A GEO analysis on your brand, before and after every congress:

• Maps which brands AI surfaces — and those it doesn’t — for any tumor, mechanism, or competitive set
• Tracks sentiment, depth, and source mix across the four leading AI surfaces
• Shows which sources are shaping what AI knows.
• Re-runs on demand to track narrative shifts around launches, congresses, and competitive reads